NCT02689245View on ClinicalTrials.gov

Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 26, 2016

Primary Completion Date

March 13, 2018

Study Completion Date

March 13, 2018

Conditions

Acute on Chronic Liver Failure

Interventions

DRUG

Tenofovir

DRUG

Fecal Microbiota Transplantation (FMT)

Trial Locations (1)

110070

Institute of liver and Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT02689245 - Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure. | Biotech Hunter | Biotech Hunter